SEC Filings

Form 8-K
ARRAY BIOPHARMA INC filed this Form 8-K on 09/15/2017
Document Outline
Entire Document (313.3 KB)
Subdocument 1 - 8-K - 8-K
Page 1 - UNITED STATES
Page 2 - Item 1.01 Entry into a Material Definitive Agreement.
Page 3 - Item 9.01 Financial Statements and Exhibits.
Page 4 - EXHIBIT INDEX
Page 5 - SIGNATURE
Subdocument 2 - EX-1.1 - EX-1.1
Page 1 - Exhibit 1.1
Page 2 - Purchase of the Shares
Page 3 - Representations and Warranties of the Company
Page 4 - Pricing Disclosure Package
Page 5 - provided
Page 6 - No Material Adverse Change.
Page 7 - Stock Options.
Page 8 - No Violation or Default.
Page 9 - Independent Accountants
Page 10 - No Undisclosed Relationships
Page 11 - Clinical Studies
Page 12 - No Labor Disputes.
Page 13 - Disclosure Controls
Page 14 - eXtensible Business Reporting Language.
Page 15 - No Conflicts with Sanctions Laws.
Page 16 - Forward-Looking Statements.
Page 17 - Delivery of Copies.
Page 18 - Ongoing Compliance.
Page 19 - Clear Market.
Page 20 - provided
Page 21 - Officer s Certificate.
Page 22 - No Legal Impediment to Issuance.
Page 23 - Indemnification of the Company.
Page 24 - Contribution.
Page 25 - Non-Exclusive Remedies.
Page 26 - N/A
Page 27 - Persons Entitled to Benefit of Agreement
Page 28 - Counterparts.
Page 29 - Signature Page to Underwriting Agreement
Page 30 - N/A
Page 31 - Pricing Disclosure Package
Page 32 - Pricing Term Sheet
Page 33 - Representative
Page 34 - provided
Subdocument 3 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - Our opinion is limited to the matters stated herein and no opinion is implied or may be inferred bey
Subdocument 4 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - Forward-Looking Statement
Subdocument 5 - EX-99.2 - EX-99.2
Page 1 - Exhibit 99.2
Page 2 - About Array BioPharma